Search

Bausch Health Cos Inc

Cerrado

SectorSanidad

8.17 2.64

Resumen

Variación precio

24h

Actual

Mínimo

8.11

Máximo

8.19

Métricas clave

By Trading Economics

Ingresos

186M

446M

Ventas

89M

2.9B

P/B

Media del Sector

13.286

51.78

BPA

1.77

Margen de beneficios

15.165

Empleados

20,300

EBITDA

254M

1.3B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+1.87% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

627M

3B

Apertura anterior

5.53

Cierre anterior

8.17

Bausch Health Cos Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 nov 2026, 00:02 UTC

News

Pfizer Inc. shares declined modestly during after-market hours, continuing a trend of lower performance and remaining below the 20-day moving average.

7 nov 2026, 00:02 UTC

News

Opendoor Technologies Inc. shares rose in after-market trading, reflecting a strong performance amid broader market strength.

7 nov 2026, 00:02 UTC

News

JP Morgan maintains Overweight rating on Cloudflare, Inc. and raises price target to $375 in a report published today.

7 nov 2026, 00:02 UTC

News

Hawaiian Electric Industries reported Q3 2026 net income of $35 million, up from $31 million a year ago, with revenue rising to $1.01 billion.

7 nov 2026, 00:02 UTC

News
Social Media

Gogo Inc. shares advanced during after-market hours amid a significant short squeeze, with trading volumes approximately 20 times the normal level.

7 nov 2026, 00:02 UTC

News

A class action lawsuit has been filed against AppLovin Corporation by Pomerantz LLP, alleging false statements about AI model development and following disappointing quarterly results.

7 nov 2026, 00:01 UTC

News

UBS upgraded JinkoSolar Holding Co., Ltd. to a Buy rating and set a price target of $17 in a report published after market hours.

7 nov 2026, 00:01 UTC

News

Shares gain in after-market trading despite negative outlook revision.

6 nov 2026, 23:51 UTC

News

UBS maintains a Sell rating on Dropbox Inc and raises its price target to $26, contributing to the stock's after-market decline.

6 nov 2026, 23:51 UTC

News

Viridian Therapeutics will host a conference call on November 9, 2026, to present data from its VRDN-008 phase 1 clinical trial and discuss development plans.

6 nov 2026, 23:41 UTC

News

Citigroup reaffirms Buy rating on Cummins Inc and raises price target to $525, with shares advancing in after-market trading.

6 nov 2026, 23:36 UTC

News

Ingredion Inc reported Q3 2026 net sales of $1.79 billion and net income of $142 million, while shares traded higher in after-market hours.

6 nov 2026, 23:26 UTC

News

Citigroup maintains Neutral rating on HubSpot, lowering its price target to $230, reflecting ongoing assessment of the company's performance.

6 nov 2026, 23:26 UTC

News

Citigroup maintains its Buy rating on Aptiv PLC and raises its price target to $68, contributing to a modest rebound in after-market trading.

6 nov 2026, 23:16 UTC

News

UBS upgraded JinkoSolar Holding Co., Ltd. to Buy and set a price target of $17, reflecting a positive outlook on the company's performance.

6 nov 2026, 23:12 UTC

News

JP Morgan maintains Overweight rating on Cloudflare, Inc. and raises price target to $375, a development published shortly before Friday's market close.

6 nov 2026, 23:11 UTC

News

Truist Securities raises Insulet Corporation's price target to $160.00 from $153.00 while maintaining a Hold rating, as shares decline in after-market trading.

6 nov 2026, 23:11 UTC

News

Lemonade Inc filed a mixed shelf registration statement for potential issuance of securities, contributing to its modest price increase in after-market trading.

6 nov 2026, 23:11 UTC

News

Boston Scientific shares advanced in after-market trading, recovering from three sessions of declines, despite S&P Global Ratings revising its outlook to negative.

6 nov 2026, 23:06 UTC

News

Pfizer Inc. shares traded modestly lower during after-market hours on Friday, continuing a downward trend that began shortly after the market closed.

6 nov 2026, 23:06 UTC

Social Media
News

NVIDIA Corporation's shares advanced after a rebound in the technology sector, aligning with broader gains across Wall Street amid renewed interest in AI-related stocks.

6 nov 2026, 23:06 UTC

News

NIO Inc. shares are trading lower in after-market hours as the CEO calls for national limits on electric vehicle weight in China, citing infrastructure concerns.

6 nov 2026, 23:06 UTC

News

U.S. State Department approves potential $1.08 billion sale of UH-60M Blackhawk helicopters to Mexico, enhancing Lockheed Martin's position in the defense sector.

6 nov 2026, 23:06 UTC

News

Citigroup maintains a Neutral rating on Wendy's Co and raises its price target to $8, reflecting the firm's assessment of the company's performance.

6 nov 2026, 23:06 UTC

News

Citigroup maintains its Buy rating on Unity Software Inc. and raises the price target to $59, reflecting confidence in the company's growth prospects.

6 nov 2026, 23:02 UTC

News

Hawaiian Electric Industries reports Q3 2026 net income of $35 million, boosted by $64 million in pre-tax gains, with revenue rising to $1.01 billion.

6 nov 2026, 23:02 UTC

News
Correlated Moves

ON Semiconductor is trading higher in after-market hours, reaching its highest point since Friday's close, while ASE Technology has also advanced.

6 nov 2026, 23:02 UTC

News
Social Media

Lam Research Corporation announced a $25 billion share buyback program and a quarterly dividend of $0.33, contributing to a significant increase in its stock price.

6 nov 2026, 23:02 UTC

News

Airbnb reports Q3 revenue growth of 19% to $4.87 billion and EPS of $3.16, exceeding expectations; announces $12 billion buyback program and raises 2026 outlook.

6 nov 2026, 23:02 UTC

News

A class action lawsuit has been filed against AppLovin Corporation by Kaplan Fox & Kilsheimer LLP, alleging misleading statements about its AI video tool development.

Comparación entre iguales

Cambio de precio

Bausch Health Cos Inc previsión

Precio Objetivo

By TipRanks

1.87% repunte

Estimación a 12 Meses

Media 8.333 USD  1.87%

Máximo 10 USD

Mínimo 7 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bausch Health Cos Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

3 ratings

0

Comprar

3

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat